Analysts think APM stock price could increase by 2192%
Aug 02, 2024, 6:25 AM
-19.38%
What does APM do
Aptorum Group Ltd. is a pharmaceutical company focused on developing therapeutic assets for diseases with unmet medical needs, specifically in oncology and infectious diseases. The company operates two business segments: Therapeutics, advancing drug projects like ALS-4 for infectious disease and SACT-1 for cancer, and Non-Therapeutics, which includes diagnostics like PathsDx Test and natural supplements.
2 analysts think APM stock price will increase by 2192.13%. The current median analyst target is $81.60 compared to a current stock price of $3.56. The lowest analysts target is $80.80 and the highest analyst target is $84.00.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
